Document is current
Any future updates will be listed below
-
Authors
Halperin, Daniel T. https://orcid.org/0000-0003-1557-5379
Hearst, Norman https://orcid.org/0000-0003-1218-9173
Hodgins, Stephen https://orcid.org/0000-0001-8365-3311
Bailey, Robert C. https://orcid.org/0000-0002-9202-1794
Klausner, Jeffrey D. https://orcid.org/0000-0002-6922-7364
Jackson, Helen
Wamai, Richard G. https://orcid.org/0000-0001-6566-5159
Ladapo, Joseph A. https://orcid.org/0000-0002-8518-4800
Over, Mead
Baral, Stefan https://orcid.org/0000-0002-5482-2419
Escandón, Kevin https://orcid.org/0000-0002-7173-7486
Gandhi, Monica https://orcid.org/0000-0002-7025-1994
- License Information
-
More Information
Article History
Received: 28 June 2021
Accepted: 22 October 2021
First Online: 13 November 2021
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Kevin Escandón and Dr. Stefan Baral are Senior Editorial Board Members for <i>BMC Infectious Diseases.</i> These authors were not involved in any of the decisions regarding review of the manuscript or its acceptance. Two in-house Editors for the BMC Series and two anonymous expert reviewers assessed this manuscript. Dr. Jeffrey D. Klausner serves as an independent medical director of Curative, Inc., a SARS-CoV-2 testing and vaccination company. The other authors declare no conflicts of interest. The authors confirm that they have read BMC’s guidance on competing interests. Views expressed here are solely those of the authors and do not represent the position or policy of any institution or organization.
